We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.42%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$40.8B
AUM Growth
-$2.75B
(-6.3%)
Cap. Flow
-$4B
Cap. Flow
% of AUM
-9.79%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,449
New
354
Increased
347
Reduced
344
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$612M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$454M |
| 3 |
BP
BP
|
+$442M |
| 4 |
TSMC
TSM
|
+$416M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$959M |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
UnitedHealth
UNH
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$508M |
| 5 |
Walt Disney
DIS
|
+$409M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.15% |
| 2 | Healthcare | 18.68% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$454B
| $1.11B | 2.72% |
11,980,294
+3,763,730
| +46% | +$368M |
|
2
Adobe
ADBE
$84.3B
| $1.02B | 2.5% |
4,192,460
-598,624
| -12% | -$142M |
|
3
Mastercard
MA
$469B
| $934M | 2.29% |
4,752,418
-210,192
| -4% | -$39.5M |
|
4
Home Depot
HD
$324B
| $891M | 2.18% |
4,568,141
-645,577
| -12% | -$121M |
|
|
5
Microsoft
MSFT
$2.83T
| $837M | 2.05% |
8,483,904
+6,313,504
| +291% | +$612M |
|
|
6
Bristol-Myers Squibb
BMY
$126B
| $771M | 1.89% |
13,932,845
+7,362,915
| +112% | +$398M |
|
7
Canadian National Railway
CNI
$79.2B
| $748M | 1.83% |
9,146,419
-581,521
| -6% | -$46.2M |
|
|
8
TSMC
TSM
$2.16T
| $699M | 1.71% |
19,108,721
+10,518,996
| +122% | +$416M |
|
9
Intuit
INTU
$77B
| $617M | 1.51% |
3,018,808
+358,704
| +13% | +$68.8M |
|
10
Visa
V
$669B
| $525M | 1.29% |
3,965,681
+1,731,640
| +78% | +$223M |
|
11
Biogen
BIIB
$29.6B
| $524M | 1.28% |
1,806,787
+662,933
| +58% | +$186M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $492M | 1.21% |
6,197,699
+3,397
| +0.1% | +$282K |
|
|
RDS.A
13
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $491M | 1.2% |
7,086,509
+6,556,109
| +1,236% | +$454M |
|
|
14
BP
BP
$113B
| $454M | 1.11% |
10,568,523
+10,520,308
| +21,820% | +$442M |
|
15
Automatic Data Processing
ADP
$97.1B
| $453M | 1.11% |
3,375,684
-46,239
| -1% | -$5.86M |
|
16
Salesforce
CRM
$129B
| $413M | 1.01% |
3,025,515
-843,823
| -22% | -$108M |
|
17
TJX Companies
TJX
$170B
| $392M | 0.96% |
8,238,520
+6,856,180
| +496% | +$301M |
|
18
Berkshire Hathaway Class B
BRK.B
$1.06T
| $380M | 0.93% |
2,034,178
-119,257
| -6% | -$23.2M |
|
19
IBM
IBM
$195B
| $378M | 0.93% |
2,832,377
-1,296,493
| -31% | -$181M |
|
20
Comcast
CMCSA
$78.3B
| $376M | 0.92% |
11,456,994
-10,218,913
| -47% | -$333M |
|
21
Canadian Pacific Kansas City
CP
$82B
| $368M | 0.9% |
10,051,035
+6,120,250
| +156% | +$225M |
|
22
HCA Healthcare
HCA
$83.5B
| $361M | 0.88% |
3,522,097
+755,384
| +27% | +$76.4M |
|
23
iShares MSCI Taiwan ETF
EWT
$10.2B
| $361M | 0.88% |
10,016,899
+8,944,165
| +834% | +$330M |
|
24
Johnson & Johnson
JNJ
$624B
| $331M | 0.81% |
2,731,113
-395,006
| -13% | -$49.3M |
|
|
RHT
25
DELISTED
Red Hat Inc
RHT
| $330M | 0.81% |
2,452,518
+217,368
| +10% | +$35.1M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Arrowstreet Capital held 1,449 positions worth $40.8B, down 6.3% from $43.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital withdrew a net $4B in Q2 2018, closing 396 positions and reducing 344 holdings. Its most notable exit was Applied Materials, an estimated $508M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Arrowstreet Capital opened a new position in Stellantis worth $85.1M.
- Arrowstreet Capital's largest Q2 2018 buy was Stellantis: 4,458,651 shares worth $85.1M.
- Arrowstreet Capital added most to Microsoft in Q2 2018, an estimated $612M increase.
- Arrowstreet Capital's biggest Q2 2018 reduction was Boeing, cutting an estimated $959M.
- Arrowstreet Capital fully exited Applied Materials in Q2 2018, selling an estimated $508M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $40.8B portfolio in Q2 2018.
- Arrowstreet Capital opened 354 new positions and closed 396 in Q2 2018.
- Arrowstreet Capital's portfolio value fell 6.3% quarter-over-quarter to $40.8B.
Based on Arrowstreet Capital's 13F filing for Q2 2018, filed 14 Aug 2018.